Targeting Aurora A Kinase Enhance the CDK4/6 Inhibitor Sensitivity in HR+/HER2- Breast Cancer
Oncology Research · 2026 · 1-10
DOI: 10.32604/or.2026.081653 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Juan Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Aurora Kinase A, Breast Neoplasms, Protein Kinase Inhibitors, Erb-b2 Receptor Tyrosine Kinases. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Oncology Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, China.
- Department of Pathology, Biobank, Shenzhen Second People's Hospital, Shenzhen University, Shenzhen, China.
Zitieren
APA
Wu, J., Wang, Y., Yan, H., Li, J., Quan, C., Yuan, J., & Sun, S. (2026). Targeting Aurora A Kinase Enhance the CDK4/6 Inhibitor Sensitivity in HR+/HER2- Breast Cancer. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.081653
Vancouver
Wu J, Wang Y, Yan H, Li J, Quan C, Yuan J, et al. Targeting Aurora A Kinase Enhance the CDK4/6 Inhibitor Sensitivity in HR+/HER2- Breast Cancer. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.081653
BibTeX
@article{Wu2026,
author = {Wu, Juan and Wang, Yue and Yan, Honglin and Li, Juanjuan and Quan, Chuntao and Yuan, Jingping and Sun, Shengrong},
title = {Targeting Aurora A Kinase Enhance the CDK4/6 Inhibitor Sensitivity in HR+/HER2- Breast Cancer},
journal = {Oncology Research},
year = {2026},
volume = {0},
number = {0},
pages = {1--10},
doi = {10.32604/or.2026.081653}
}
EUVIMED